ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

St. Jude Director Cites Poor Housing’s Toll on Children, March 28, 1971

May 19, 2021

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

In Brief: Indiana Univ. Wins NCI Cancer Center Grant; Stephen Straus To direct CAM Center At NIH

October 8, 1999

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001

In Brief: Pagano to Retire As Lineberger Director; Nursing Society Elects Yarbro As President

September 20, 1996